Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
PCSA
PCSA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PCSA News
Penguin Solutions Reports Q1 Earnings of $0.49, Shares Up 5.3%
Jan 07 2026
Benzinga
Processa Completes Enrollment of 20 Patients for NGC-Cap Efficacy Study
Jan 05 2026
Globenewswire
Weekly Update: CYTK Receives Initial FDA Approval, INSM Concludes Rhinosinusitis Research, XOMA Purchases GBIO
Dec 20 2025
NASDAQ.COM
What’s Driving the Surge in Processa Pharmaceuticals Stock Following Breast Cancer Trial Results?
Dec 17 2025
Benzinga
Processa Pharmaceuticals Reports Enhanced Efficacy of NGC-Cap in Phase 2 Breast Cancer Study
Dec 17 2025
Globenewswire
Processa Pharmaceuticals Reports Enhanced Efficacy of NGC-Cap Therapy in Phase 2 Study
Dec 17 2025
Newsfilter
Butterfly Network and Citius Pharma Boost Biotech Activity in After-Hours Trading
Nov 24 2025
NASDAQ.COM
Processa Pharmaceuticals to Present Poster on Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025
Nov 05 2025
Newsfilter
Biotech Stocks Soar in After-Hours Trading: PCSA, PALI, and QTTB Top the Charts in Volume and Speculation
Oct 08 2025
NASDAQ.COM
TELO, PCSA, RVPH, NMTC, BRTX Experience After-Hours Trading Surge Amid Limited News and Specific Updates
Oct 07 2025
NASDAQ.COM
Processa Pharmaceuticals Provides Portfolio and Business Update
Jul 01 2025
Newsfilter
Why Sequans Communications Shares Are Trading Higher By Over 42%; Here Are 20 Stocks Moving Premarket
Jun 23 2025
Benzinga
Why Cheetah Mobile Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
Jun 20 2025
Benzinga
Crude Oil Rises Sharply; Jabil Earnings Top Views
Jun 17 2025
Benzinga
Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering
Jun 17 2025
Newsfilter
US Stocks Lower; Retail Sales Decline In May
Jun 17 2025
Benzinga
Show More News
